Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 82
Filtrar
1.
J Endocrinol Invest ; 46(5): 903-913, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-36454439

RESUMEN

BACKGROUND: The single nucleotide polymorphisms in the TLR4 gene can decrease or increase the response to lipopolysaccharide, increasing the susceptibility to inflammatory diseases, affecting the expression or receptor function by inducing a low-grade chronic inflammatory response. PURPOSE: The objective of this study was to evaluate the association of SNPs - 2570 A > G (rs2737190), - 2081 G > A (rs10983755), 896 A > G (rs 4986790), and 1196 C > T (rs4986791) of the TLR4 gene with obesity and metabolic alterations in the young population. RESULTS: In this study, it was found that the carriers of the heterozygous genotype of the SNPs - 2081 G > A, 896 A > G, and 1196 C > T confer a higher risk of developing obesity (OR = 3.73, p = 0.018; OR = 5.66, p = 0.014, and OR = 8.95, p = 0.014, respectively). Also, with the lipid profile, the SNP - 2081 G > A was associated with total cholesterol (TC) ≥ 200 mg/dL (OR = 3.91, p = 0.020) and Kannel index > 3% (OR = 4.00, p = 0.008). The SNP 896 A > G was associated with LDL-c ≥ 100 mg/dL (OR = 3.64, p = 0.040) and Kannel index > 3% (OR = 4.33, p = 0.016), and the SNP 1196 C > T was associated with TC ≥ 200 mg/dL (OR = 4.37, p = 0.048), Castelli index > 4.5/> 5% (OR = 5.33, p = 0.016), and Kannel index > 3% (OR = 16.00, p = 0.001). Finally, the AGGT haplotype was associated with Castelli index > 4.5/> 5% (OR = 5.40, p = 0.015) and Kannel index > 3% (OR = 10.46, p < 0.001), and the AAAC haplotype was associated with obesity (OR = 3.56, p = 0.020), TC ≥ 200 mg/dL (OR = 4.04, p = 0.007), LDL-c ≥ 100 mg/dL (OR = 2.98, p = 0.030) and Kannel index > 3% (OR = 4.20, p = 0.002). CONCLUSION: The heterozygous genotype of the SNPs - 2081 G > A, 896 A > G and 1196 C > T of the TLR4 gene was associated with altered lipid profile and development of obesity in young university students of Guerrero State, Mexico.


Asunto(s)
Obesidad , Receptor Toll-Like 4 , Humanos , Haplotipos , Receptor Toll-Like 4/genética , Proyectos Piloto , LDL-Colesterol , Genotipo , Obesidad/epidemiología , Obesidad/genética , Polimorfismo de Nucleótido Simple , Predisposición Genética a la Enfermedad
2.
Poult Sci ; 99(11): 5946-5959, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-33142512

RESUMEN

Four experiments were conducted to estimate the optimal standardized ileal digestible (SID) level of branched-chain amino acids in low-protein diets during the starter, grower, and finisher periods, using the response surface methodology, and to study their effects on performance and mRNA expression of genes involved in the mechanistic target of rapamycin (mTOR) pathway of broiler chickens from 8 to 21 D of age. In experiments 1, 2, and 3, a total of 1,500 Cobb male broiler chickens were assigned to 15 diets of a central composite rotatable design (CCD) of response surface methodology containing 5 levels of SID Leu, Val, and Ile with 5 replicate pens of 20 birds each. A 3-factor, 5-level CCD platform was used to fit the second-order polynomial equation of broiler performance. In experiment 4, a total of 540 8-day-old Cobb male broiler chickens were distributed in a completely randomized 2 x 3 x 3 factorial arrangement with 2 SID Leu levels (1.28 or 1.83%), 3 SID Val levels (0.65, 0.90, or 1.20%), and 3 SID Ile levels (0.54, 0.79, or 1.09%) for a total of 18 treatments with 5 replicate cages of 6 birds each. High Leu levels impaired (P < 0.05) gain:feed when birds were fed marginal Val or Ile diets. However, gain:feed was restored when both Val and Ile were supplemented to reach adequate or high levels. High Leu levels increased (P < 0.05) mRNA expression of S6K1 and eEF2 genes only in birds fed high Ile levels. Dietary SID Leu, Val, and Ile levels required for gain:feed optimization in low-protein diets were estimated at 1.37, 0.94, and 0.87% during the starter period; 1.23, 0.82, and 0.75% during the grower period; and 1.15, 0.77, and 0.70% during the finisher phase, respectively. Higher Val and Ile levels are required to optimize the effect of Leu supplementation on mRNA expression of mTOR pathway genes in the pectoralis major muscle of broilers from day 1 to 21 after hatch.


Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Animales , Pollos , Dieta con Restricción de Proteínas , Isoleucina , Leucina , Valina , Alimentación Animal/análisis , Animales , Pollos/genética , Dieta con Restricción de Proteínas/veterinaria , Suplementos Dietéticos , Crecimiento/efectos de los fármacos , Isoleucina/administración & dosificación , Leucina/farmacología , Masculino , Distribución Aleatoria , Valina/administración & dosificación
3.
Int J Immunopathol Pharmacol ; 34: 2058738420907186, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32138573

RESUMEN

The goals of our study were to determine the possible association of interleukin (IL)-31 with Th17 cytokine profile in serum and to quantify retinoic acid-related orphan receptor C (RORC) mRNA expression in psoriatic arthritis (PsA) patients. This cross-sectional study was conducted in 50 patients with PsA and 30 control subjects (CS) matched by age and gender. The cytokine serum levels were quantified by magnetic bead-based assay using the Bio-Plex MAGPIX system, and RORC mRNA expression was determined by quantitative polymerase chain reaction (qPCR). As a result, significant differences in IL-31 were observed between study groups (77.23 pg/mL in PsA vs 64.4 pg/mL in CS, P < 0.001) and Th17 cytokine profile serum levels (IL-17A: 6.36 pg/mL in PsA vs 2.97 pg/mL in CS, P = 0.02; IL-17F: 44.15 pg/mL in PsA vs 23.36 pg/mL in PsA, P = 0.01; IL-17E: 3.03 pg/mL in PsA vs 0.82 pg/mL in CS, P < 0.001; IL-21: 36.45 pg/mL in PsA vs 12.44 pg/mL in CS, P = 0.02); however, significant differences were not observed for IL-23 (31.2 pg/mL in PsA vs 53.26 pg/mL in CS, P = 0.58). Furthermore, positive correlations between IL-31 and Th17 cytokine profile serum levels were found (IL-17A: rs = 0.64, P < 0.001; IL-17F: rs = 0.73, P < 0.001; IL-17E: rs = 0.70, P < 0.001; IL-21: rs = 0.54, P = 0.002; IL-23: rs = 0.5, P < 0.01). Regarding RORC gene expression, the PsA group showed an increase of 6.85-fold compared to the CS group. We did not find any association between the serum levels of cytokines and RORC gene expression. In conclusion, in PsA, there are increased serum levels of IL-31, IL-17A, IL-17F, IL-17E, and IL-21, but not IL-23. Moreover, there was a positive correlation of IL-31 with the Th17 cytokine profile and a high RORC gene expression. Altogether, these findings suggest a proinflammatory contribution of IL-31 in close association with the Th17 cytokine profile in PsA.


Asunto(s)
Artritis Psoriásica/metabolismo , Artritis Psoriásica/patología , Citocinas/metabolismo , Inflamación/metabolismo , Inflamación/patología , Interleucinas/metabolismo , Células Th17/metabolismo , Adulto , Anciano , Estudios Transversales , Citocinas/sangre , Femenino , Humanos , Interleucina-17/genética , Interleucina-17/metabolismo , Interleucinas/genética , Masculino , Persona de Mediana Edad , Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares/genética , Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares/metabolismo
4.
Autoimmunity ; 53(2): 71-77, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-31829037

RESUMEN

Systemic lupus erythematosus (SLE) involves a broad range of factors that contribute to the development of the disease and its comorbidities. Genetic predisposition influences the development of SLE, and the -675 4G/5G PAI-1 polymorphism has been associated with several pathologies with a chronic inflammatory component. Our objective was to investigate the genetic association between the -675 4G/5G PAI-1 polymorphism with SLE, its clinical manifestations, and comorbidities in a Mexican-Mestizo population. The -675 PAI-1 polymorphism was determined by PCR-RFLP in 716 subjects: 293 SLE patients and 423 control subjects. Significant associations for SLE genetic susceptibility were found in carriers of 4G/5G (OR = 2.63; CI 1.81-3.87; p < .001) and 4G/4G (OR = 2.70; CI 1.62-4.51; p < .001) genotype in comparison with the 5G/5G genotype; 4G allele carriers also presented genetic risk for SLE (OR = 1.63; CI 1.31-2.03; p < .001) compared to the 5G allele. Following a dominant genetic model, a similar association was found with the 4G allele to SLE (OR = 2.66; CI1.84-3.84; p < .001). The 4G/5G genotype was associated with shorter disease duration (p = .039), as well as lower levels of haemoglobin (p = .001) and haematocrit (p = .009); the need for prednisone treatment (p = .001), higher BMI (p = .03), presence of type 2 DM (p = .015), clinical activity (Mex-SLEDAI = 57%; p = .047), Chronicity (SLICC-ACR = 0; p = .015) and CRP levels (p = .015) were associated with 5G/5G genotypes. In conclusion, the -675 4G/5G and 4G/4G PAI-1genotypes were found as genetic risk markers of susceptibility for SLE in the Mexican-Mestizo population, and each genotype could influence the clinical manifestations and comorbidities differently in SLE.


Asunto(s)
Predisposición Genética a la Enfermedad , Lupus Eritematoso Sistémico/genética , Inhibidor 1 de Activador Plasminogénico/genética , Adolescente , Adulto , Alelos , Análisis del Polimorfismo de Longitud de Fragmentos Amplificados , Enfermedad Crónica/tratamiento farmacológico , Enfermedad Crónica/epidemiología , Comorbilidad , Estudios Transversales , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/genética , Dislipidemias/epidemiología , Dislipidemias/genética , Femenino , Frecuencia de los Genes , Hematócrito , Hemoglobinas/análisis , Heterocigoto , Humanos , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/tratamiento farmacológico , Lupus Eritematoso Sistémico/epidemiología , Masculino , México/epidemiología , Persona de Mediana Edad , Obesidad/epidemiología , Obesidad/genética , Polimorfismo de Longitud del Fragmento de Restricción , Prednisona/uso terapéutico , Adulto Joven
5.
Clin Rheumatol ; 38(8): 2089-2097, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-30911943

RESUMEN

INTRODUCTION: Prolactin (PRL) is a sex hormone with immunomodulatory properties, and it is associated with the clinical activity of rheumatoid arthritis (RA). The -1149G>T polymorphism at the prolactin (PRL) gene has been associated with autoimmune diseases, but its functional effect is unclear. OBJECTIVE: To analyze the association of the PRL -1149G>T polymorphism with disease susceptibility, mRNA, and protein expression of PRL in RA patients from Southern Mexico. METHODS: We included 300 RA patients and 300 control subjects (CS). Genotypes were identified by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique, the PRL mRNA expression was determined by real-time PCR, and PRL serum levels were measured by enzyme-linked immunosorbent assay. RESULTS: Applying genetic models of inheritance (dominant, recessive, and additive), we found an association between the T allele and decreased RA susceptibility (OR = 0.55, 95% CI 0.35-0.87, p = 0.009; OR = 0.09, 95% CI 0.012-0.76, p = 0.011; OR = 0.49, 95% CI 0.32-0.76, p = 0.001, respectively). RA patients had higher mRNA expression and soluble levels of PRL than CS (p < 0.05). The PRL serum levels were similar in RA and CS according to genotypes. However, in CS, carriers of GT and TT genotypes showed lower PRL mRNA expression than GG genotype carriers (7.1-fold and 20-fold respectively, p = 0.006). CONCLUSIONS: This study demonstrated that the PRL -1149T allele is a genetic marker of decrease risk to RA in population from Southern Mexico, and it is associated with low PRL mRNA. KEY POINTS: • PRL -1149T allele is a marker of decreased RA susceptibility in population from southern Mexico. • PRL -1149TT genotype is associated with low PRL mRNA expression. • RA patients have higher mRNA expression and soluble levels of PRL than healthy subjects. • PRL serum levels are higher in those RA patients with < 2 years of disease evolution.


Asunto(s)
Artritis Reumatoide/genética , Polimorfismo de Nucleótido Simple , Prolactina/genética , Adulto , Anciano , Alelos , Artritis Reumatoide/diagnóstico , Artritis Reumatoide/epidemiología , Enfermedades Autoinmunes/diagnóstico , Enfermedades Autoinmunes/epidemiología , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , México/epidemiología , Persona de Mediana Edad , Polimorfismo de Longitud del Fragmento de Restricción , Prolactina/sangre , ARN Mensajero/genética , Riesgo
6.
Medwave ; 19(11): e7750, 2019.
Artículo en Inglés, Español | LILACS | ID: biblio-1049139

RESUMEN

INTRODUCCIÓN La laparoscopía es actualmente el estándar en el manejo de la endometriosis profunda. Sin embargo, requiere de un entrenamiento específico e involucra la realización de procedimientos complejos y asociados a una alta tasa de complicaciones. Por lo anterior en Chile y Latinoamérica, la endometriosis profunda es frecuentemente manejada de manera inadecuada. OBJETIVO Describir nuestra experiencia en el enfrentamiento clínico y manejo quirúrgico laparoscópico de la endometriosis profunda, durante los últimos siete años. MÉTODOS Estudio de cohorte retrospectivo de 137 pacientes consecutivas operadas y con confirmación histológica de endometriosis profunda. Se recolectaron los datos demográficos, datos quirúrgicos, complicaciones, resultados reproductivos y seguimiento. RESULTADOS Todas las cirugías fueron completadas por laparoscopía, sin conversión. La dismenorrea y la dispareunia fueron los síntomas más frecuentes en 85,4 y 56,9%, respectivamente. La localización más frecuente de endometriosis profunda fueron los ligamentos úterosacros, coexistiendo un endometrioma en 48,9% de los casos. La mediana de tiempo operatorio fue de 140 minutos, siendo significativamente más prolongado en casos con compromiso intestinal (p < 0,0001). Quince pacientes (10,9%) presentaron complicaciones. El seguimiento medio fue de 24,5 meses. La tasa de embarazo fue de 58,1% y 90% de las pacientes reportó una mejoría significativa de su sintomatología. CONCLUSIONES El manejo laparoscópico de la endometriosis profunda es efectivo y seguro, pero debe reservarse a centros especializados y con disponibilidad de equipo multidisciplinario.


BACKGROUND Laparoscopy has become the standard of care in the surgical management of deep infiltrating endometriosis (DIE). However, it is a challenging procedure with a high complication rate. Despite the benefits of the minimally invasive approach, DIE resection is often performed by surgeons without adequate training, especially in developing countries like Chile. OBJECTIVE To asses our experience in the diagnosis and laparoscopic management of DIE during seven years. METHODS A retrospective cohort study of data including 137 patients with pathology-proven DIE. Surgical and fertility outcomes were evaluated. RESULTS All procedures were performed laparoscopically without conversion. Dysmenorrhea and dyspareunia were the most common symptoms in 85.4% and 56.9%, respectively. Uterosacral ligaments were the most common DIE location. Endometrioma was present in 48.9% of cases. Median operative time was 140 minutes; however, it was longer in cases requiring bowel surgery (p < 0.0001). The complication rate was 10.9%. Median follow-up was 24.5 months. The pregnancy rate was 58.1% and 90% of patients reported significant symptom relief after surgery. CONCLUSION Laparoscopic surgical management of DIE is effective and safe but it must be performed in tertiary centers with the availability of multidisciplinary teams.


Asunto(s)
Humanos , Femenino , Adulto , Complicaciones Posoperatorias/epidemiología , Laparoscopía/métodos , Endometriosis/cirugía , Grupo de Atención al Paciente/organización & administración , Chile , Estudios Retrospectivos , Estudios de Cohortes , Estudios de Seguimiento , Resultado del Tratamiento , Dismenorrea/etiología , Dismenorrea/epidemiología , Dispareunia/etiología , Dispareunia/epidemiología , Endometriosis/diagnóstico , Endometriosis/patología
7.
J Anim Physiol Anim Nutr (Berl) ; 102(2): e768-e776, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29193326

RESUMEN

Two experiments were conducted to study the effect of standardized ileal digestible (SID) leucine and valine levels on tibiotarsus bone characteristics and the incidence of tibial dyschondroplasia of broilers from day 1 to 21 (Experiment I) and day 21 to 42 post-hatch (Experiment II). Each experimental phase was evaluated independently. In both experiments, a total of 1,500 one-day-old Cobb 500 male broiler chickens were distributed in a completely randomized design 5 × 5 factorial arrangement for a total of 25 treatments. The SID leucine and valine levels were ranged from 10.0 to 19.6 g/kg, and 6.0 to 12.0 g/kg from day 1 to 21 post-hatch, respectively, while day 21 to 42 post-hatch ranged from 10.0 to 18.0 g leucine/kg, and 5.2 to 11.2 g valine/kg. Serum calcium and phosphorus, bone concentrations of calcium, phosphorus and ash, diameter and Seedor index of the tibiotarsus were not affected (p > .05) by the treatments at 21 or 42 days of age. There was an interaction (p ≤.06) between the SID levels of leucine and valine on tibiotarsus breaking strength at 21 days, but not at 42 days of age (p > .05). Tibiotarsus breaking strength was maximized in broilers from day 1 to 21 with the dietary levels of leucine and valine at 14.2 and 9.0 g/kg respectively. Dietary leucine levels reduced linearly (p < .05) the hypertrophic zone of tibiotarsus cartilage at 21 days of age. Therefore, leucine and valine supplementation interact positively on bone strength of broilers from day 1 to 21 post-hatch. Leucine can be a useful amino acid for reducing the hypertrophic cartilage zone in broilers from day 1 to 21, but not from day 21 to 42 post-hatch.


Asunto(s)
Densidad Ósea/efectos de los fármacos , Pollos , Leucina/farmacología , Osteocondrodisplasias/veterinaria , Valina/farmacología , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Fenómenos Biomecánicos , Dieta/veterinaria , Suplementos Dietéticos , Masculino , Osteocondrodisplasias/etiología , Valina/administración & dosificación
8.
Poult Sci ; 97(1): 159-166, 2018 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-29077959

RESUMEN

The aim of this study was to evaluate the hepatoprotective effect of silymarin in diets contaminated or not with aflatoxin B1 (AFB1) on the productive performance and serum biochemical profile of Japanese quail (Coturnix coturnix japonica) in the laying phase. A total of 240 12-week-old Japanese quail was used in a completely randomized design in a 3 × 2 factorial scheme (additives x contaminated or not with AFB1 - 1,500 µg/kg), totaling 6 treatments and 5 replicates of 8 birds each. The additives used were silymarin (500 g/ton), adsorbent (1 kg/ton), and a control diet (without additive). Of the total aflatoxin content, 84.64% was AFB1; 4.28% was AFB2; 11.07% was AFG1; and AFG2 was not detected. The data were submitted to ANOVA, and means were compared by Tukey's test. There was no interaction (P > 0.05) between the additive and AFB1 on performance parameters. However, the inclusion of AF in diets reduced (P < 0.05) egg weight and feed intake, impairing feed conversion compared to the unchallenged groups. There was an increase (P < 0.05) in blood concentrations of aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), and creatine kinase (CK) in birds challenged with AFB1, regardless of the additive used, characterizing a possible alteration in hepatic metabolism. Serum total protein and globulin levels were reduced (P < 0.05) in birds challenged with toxins. The consumption of diets contaminated with 1,500 µg AFB1/kg altered hepatic function in quail, impairing productive performance and egg weight. The concentrations of silymarin and adsorbent evaluated in this study were not able to mitigate the negative effect of toxins on the metabolism and performance of laying quail.


Asunto(s)
Aflatoxina B1/efectos adversos , Coturnix/fisiología , Sustancias Protectoras/farmacología , Silimarina/farmacología , Aflatoxina B1/administración & dosificación , Alimentación Animal/análisis , Animales , Proteínas Aviares/sangre , Dieta/veterinaria , Suplementos Dietéticos/análisis , Sustancias Protectoras/administración & dosificación , Silimarina/administración & dosificación
9.
Poult Sci ; 96(4): 914-922, 2017 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-27664200

RESUMEN

The objective of this study was to determine the requirements and interactions between the standardized ileal digestible (SID) Leu and Val levels in low-protein diets, and their effects on performance, serum characteristics, carcass yield and diameter of muscle fibers of broiler chickens from d 21 to 42 posthatch. A total of 1,500 21-day-old Cobb 500 male broiler chickens were distributed in a completely randomized design in a 5 × 5 factorial arrangement for a total of 25 treatments with 3 replicates of 20 birds each. Treatments consisted of 5 SID Leu levels (1.0, 1.2, 1.4, 1.6, or 1.8%) and 5 SID Val levels (0.52, 0.67, 0.82, 0.97, or 1.12%). At 42 d of age, there was interaction (P < 0.05) between the SID levels of Leu and Val on feed intake and weight gain. There was a quadratic effect (P < 0.05) of Leu and Val levels on feed conversion, with minimal point estimated at the levels of 1.19 and 0.86%, respectively. Dietary Leu supplementation reduced linearly (P < 0.05) serum concentrations of triglycerides and ß-hydroxybutyrate. Dietary Leu increased (P ≤ 0.05) the fiber diameters of the pectoralis major muscle and breast yield at the levels of 1.24 and 1.13%, respectively, while the thigh yield was improved with the level of 0.71% Val. Abdominal fat decreased linearly (P < 0.05) with increasing levels of dietary Leu and Val. The SID Leu and Val levels needed to optimize weight gain and feed conversion in low-CP diets for broiler chickens from d 21 to 42 posthatch were estimated at 1.15 and 0.86%, and 1.19 and 0.86%, respectively. The supplementation of Leu and Val can reduce the abdominal fat deposition in birds fed low-CP diets during the grower phase. Leu and Val interactions can influence the performance but not the serum characteristics, carcass yield and diameter of muscle fibers of broilers fed low-protein diets. Therefore, it is necessary to consider the dietary Leu content to estimate the ideal level of Val in low-CP diets for optimum broiler performance.


Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Animales , Pollos/fisiología , Dieta con Restricción de Proteínas/veterinaria , Suplementos Dietéticos , Leucina/metabolismo , Necesidades Nutricionales , Valina/metabolismo , Alimentación Animal/análisis , Animales , Pollos/sangre , Pollos/crecimiento & desarrollo , Dieta/veterinaria , Suplementos Dietéticos/análisis , Digestión/fisiología , Íleon/fisiología , Leucina/administración & dosificación , Masculino , Distribución Aleatoria , Valina/administración & dosificación
10.
Int. j. odontostomatol. (Print) ; 10(3): 449-454, dic. 2016. ilus
Artículo en Español | LILACS | ID: biblio-840994

RESUMEN

El objetivo de este estudio fue evaluar el efecto de la radiación ultravioleta (UV) B sobre la expresión del factor de crecimiento transformante (TGF) ß1 por fibroblastos de mucosa oral, con el objetivo de dilucidar si este tipo celular puede contribuir a la expresión de TGFß1 en bermellón labial sobreexpuesto a la radiación UV. Se obtuvieron cultivos primarios de fibroblastos desde explantes de mucosa bucal, los que fueron irradiados con una dosis única de luz UVB (60 mJ/cm2). Se midió proliferación celular con el método MTT, y la expresión de TGFß1, a nivel de ARN mensajero (normalizado a GAPDH) por RT-PCR y a nivel de proteína mediante inmunofluorescencia. Se observó una disminución de la proliferación celular de los fibroblastos de mucosa oral a las 24 hrs post-irradiación en relación a los fibroblastos no irradiados (P<0,05, Mann Whitney). No se encontraron diferencias entre los fibroblastos control y los irradiados en la expresión de TGFß-1 ni a nivel de mensajero (0,5 y 6 h post-irradiación), ni de proteína (24 h post-irradiación). Los resultados sugieren que los fibroblastos de mucosa oral presentan una disminución de su proliferación en respuesta a una dosis única de radiación UVB, sin que se afecte la expresión de TGFß-1, la que fue similar a los fibroblastos no irradiados. Esto sugiere que los fibroblastos contribuirían a la producción de TGFß-1 en respuesta a la exposición crónica a UVB del bermellón labial.


The objective of this study was to characterize the effect of Ultraviolet (UV) B irradiation on the expression of transforming growth factor (TGF) ß1 by oral mucosa fibroblasts, in order to assess if these cells contribute to the production of TGFß-1 in UV-irradiated lip vermillion. Primary cultures of fibroblasts were obtained from oral mucosa explants, and were irradiated with a single dose of UVB light (60 mJ/cm2). The effects of UVB radiation on cell proliferation was evaluated by the MTT method. The effects of UVB on the expression of TGF-ß1 was analyzed by RT-PCR (normalized to GAPDH) and by immunofluorescence. The results showed a decrease in the proliferation of UVB-irradiated fibroblasts as compared to controls at 24h post-irradiation (p<0.05). No variations in the expression of TGFß1, both at the mRNA and protein level, were observed between control and UVB-irradiated fibroblasts during the first 24 h after irradiation. Oral mucosa fibroblasts have reduced proliferation in response to a single dose of UVB, but their expression of TGFß1 was not affected. This suggests that oral mucosa fibroblasts may contribute to the production of TGFß1 in the lip vermillion independent of UVB exposure.


Asunto(s)
Humanos , Mucosa Bucal/metabolismo , Mucosa Bucal/efectos de la radiación , Factor de Crecimiento Transformador beta/efectos de la radiación , Rayos Ultravioleta , Proliferación Celular , Fibroblastos/metabolismo , Factor de Crecimiento Transformador beta/metabolismo
11.
Rev. bras. ciênc. avic ; 18(3): 381-386, Jul-Set. 2016. tab
Artículo en Inglés | VETINDEX | ID: biblio-1490296

RESUMEN

Three experiments were carried out to evaluate the levels of digestible valine in diets with reduced crude protein on the performance, carcass yield and muscle fiber diameter of male broilers during the pre-starter (1 to 8 d of age), starter (9 to 21 d of age) and grower phases (21 to 42 d of age). A total of 1,080 chickens in the pre-starter phase, 900 in the starter phase and 864 in the grower phase were distributed in a completely randomized design with six treatments, consisting of a control positive diet (C+) and diets with 2 percentage points (p.p.) reduction of crude protein level and five graded levels of digestible valine (Val), with six replicates of 30, 25 and 24 birds per experimental unit, respectively. The recommended level of TID Val in the low-protein diets for broilers in the pre-starter, starter and grower stages were 1.028; 0.905 and 0.789%, respectively. The reduction of 2 percentage points of the crude protein level in diets based on corn and soybean meal impaired (p 0.05) carcass and parts yields, or abdominal fat percentage at 42 days.


Asunto(s)
Animales , Aminoácidos/análisis , Dieta con Restricción de Proteínas/veterinaria , Dieta/veterinaria , Pollos/crecimiento & desarrollo , Valina/análisis , Proteínas/fisiología
12.
R. bras. Ci. avíc. ; 18(3): 381-386, Jul-Set. 2016. tab
Artículo en Inglés | VETINDEX | ID: vti-15628

RESUMEN

Three experiments were carried out to evaluate the levels of digestible valine in diets with reduced crude protein on the performance, carcass yield and muscle fiber diameter of male broilers during the pre-starter (1 to 8 d of age), starter (9 to 21 d of age) and grower phases (21 to 42 d of age). A total of 1,080 chickens in the pre-starter phase, 900 in the starter phase and 864 in the grower phase were distributed in a completely randomized design with six treatments, consisting of a control positive diet (C+) and diets with 2 percentage points (p.p.) reduction of crude protein level and five graded levels of digestible valine (Val), with six replicates of 30, 25 and 24 birds per experimental unit, respectively. The recommended level of TID Val in the low-protein diets for broilers in the pre-starter, starter and grower stages were 1.028; 0.905 and 0.789%, respectively. The reduction of 2 percentage points of the crude protein level in diets based on corn and soybean meal impaired (p <= 0.05) the feed conversion ratio in the starter and grower stages. Likewise, the reduced-protein diets decreased (p <= 0.05) muscle fiber diameter, but did not affect (p> 0.05) carcass and parts yields, or abdominal fat percentage at 42 days.(AU)


Asunto(s)
Animales , Pollos/crecimiento & desarrollo , Dieta con Restricción de Proteínas/veterinaria , Valina/análisis , Dieta/veterinaria , Aminoácidos/análisis , Proteínas/fisiología
13.
J Dev Orig Health Dis ; 7(1): 83-9, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26349587

RESUMEN

The maternal weight gain chart proposed by Rosso and Mardones (RM) was subsequently modified by Atalah et al. (AEA). Both charts are widely used in Latin America. The purpose of this study was to compare birth length (BL) and birth weight (BW) outcomes of both charts. A prospective study of pregnant women and their offspring's was performed in Santiago, Chile. From a total sample of 27,613 pregnant women a sub-sample of 11,465 term healthy singleton pregnant women was selected for additional analyses. κ statistics was used to study the degree of agreement of both charts in the diagnosis of maternal nutritional status. Obese and underweight women were classified using both standards at the beginning of pregnancy and compared in terms of BL4250 g proportions. Sensitivity and specificity values of at risk newborns, whose categories were considered as gold standard, were obtained for obese and underweight women of each chart. There was a moderate agreement in the nutritional classification of these charts. Proportions of BL4250 g were similar at each nutritional category; however, absolute figures for at risk newborns were much higher in the RM underweight and obese women. The RM chart showed higher sensitivity values than the AEA chart. The higher sensitivity of the RM chart would support its use for prevention purposes. This chart is advisable for Latin American countries and also for most developing countries.


Asunto(s)
Peso al Nacer , Índice de Masa Corporal , Resultado del Embarazo , Adulto , Femenino , Humanos , Recién Nacido , Obesidad/diagnóstico , Embarazo , Complicaciones del Embarazo/diagnóstico , Estudios Prospectivos , Adulto Joven
14.
Rev. bras. ciênc. avic ; 16(4): 351-358, Oct.-Dec. 2014. tab
Artículo en Inglés | VETINDEX | ID: biblio-1490105

RESUMEN

This study evaluated the performance and the quality and fatty acid profile of eggs from laying hens fed diets containing mixed crude glycerin (MCG; 80% vegetable fat + 20% animal fat). A total of 240 39-week-old Hy-Line W36 laying hens were distributed according to a completely randomized experimental design into six treatments consisting of graded MCG dietary inclusion levels (0, 1.5, 3.0, 4.5, 6.0, and 7.5%), with five replicates of eight birds each. Feed intake linearly decreased (p 0.05) with increasing MCG inclusion levels. The percentages of myristic, palmitic, and -linolenic acids in the eggs linearly decreased as MCG dietary levels increased (p 0.05), while -linoleic acid, polyunsaturated fatty acids (PUFA) and -6/-3 ratio linearly increased. Excreta moisture linearly increased with increasing levels of MCG inclusion (p 0.05). MCG may be included in up to 7.5% in layer feeds without impairing performance or egg quality, but levels up to 5.54% reduce SFA egg content. However, the inclusion of MCG in layer diets increases -6/-3 ratio in the eggs.


Asunto(s)
Animales , Pollos/metabolismo , Alimentación Animal/análisis , Alimentación Animal/efectos adversos , Alimentación Animal/normas , Glicerol , Huevos/análisis , Ácidos Grasos/análisis
15.
R. bras. Ci. avíc. ; 16(4): 351-358, Oct.-Dec. 2014. tab
Artículo en Inglés | VETINDEX | ID: vti-15817

RESUMEN

This study evaluated the performance and the quality and fatty acid profile of eggs from laying hens fed diets containing mixed crude glycerin (MCG; 80% vegetable fat + 20% animal fat). A total of 240 39-week-old Hy-Line W36 laying hens were distributed according to a completely randomized experimental design into six treatments consisting of graded MCG dietary inclusion levels (0, 1.5, 3.0, 4.5, 6.0, and 7.5%), with five replicates of eight birds each. Feed intake linearly decreased (p 0.05) with increasing MCG inclusion levels. The percentages of myristic, palmitic, and -linolenic acids in the eggs linearly decreased as MCG dietary levels increased (p 0.05), while -linoleic acid, polyunsaturated fatty acids (PUFA) and -6/-3 ratio linearly increased. Excreta moisture linearly increased with increasing levels of MCG inclusion (p 0.05). MCG may be included in up to 7.5% in layer feeds without impairing performance or egg quality, but levels up to 5.54% reduce SFA egg content. However, the inclusion of MCG in layer diets increases -6/-3 ratio in the eggs.(AU)


Asunto(s)
Animales , Alimentación Animal/efectos adversos , Alimentación Animal/análisis , Alimentación Animal/normas , Pollos/metabolismo , Glicerol , Huevos/análisis , Ácidos Grasos/análisis
16.
Br Poult Sci ; 55(6): 766-73, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25269797

RESUMEN

1. Two experiments were performed to study the supplementation of valine, isoleucine, arginine and glycine (Val, Ile, Arg, Gly) in low-protein diets for broiler chickens in the starter (1-21 d; Exp. 1) and grower (22-42 d; Exp. 2) phases. 2. A low-crude protein (CP) diet was formulated to meet the requirements of all amino acids (AA) supplied by the control diet except for Val, Ile, Arg and Gly. The other experimental diets were obtained by the isolated or combined supplementation of the studied AA in the low-CP diet. 3. Growth, serum parameters and litter characteristics were taken in both of the experiments. Carcass measurements were taken in Experiment 2. 4. In the starter and grower phases, low-CP diets without supplementation resulted in birds with a poorer weight gain and feed conversion than those of the birds that received the control diet. 5. In the starter phase, individual supplementation with Val and Gly, but not Ile and Arg, restored the weight gain of the birds, while diets with the addition of Val + Gly, Val + Ile + Arg, Val + Ile + Gly and Val + Ile + Arg + Gly restored their feed conversion. 6. In the grower phase, weight gain was re-established at the same rate as the control diet for the diets supplemented with Val + Ile, Val + Ile + Arg, Val + Ile + Gly and Val + Ile + Arg + Gly. However, the feed conversion was restored only in birds that received the diet supplemented with all studied AA. 7. The supplementation of Val and Gly in low-CP diets was sufficient to avoid adverse effects in the performance and serum parameters of broilers in the starter phase. However, birds in the grower phase required the combined supplementation of Val, Ile, Arg and Gly, to prevent compromised performance.


Asunto(s)
Arginina/farmacología , Pollos/crecimiento & desarrollo , Dieta con Restricción de Proteínas/veterinaria , Glicina/farmacología , Isoleucina/farmacología , Valina/farmacología , Crianza de Animales Domésticos/métodos , Animales , Suplementos Dietéticos , Aumento de Peso/efectos de los fármacos
17.
Poult Sci ; 93(9): 2237-44, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24974392

RESUMEN

This study was conducted to assess the effect of dietary supplementation of meat-type quail breeders with guanidinoacetic acid (GAA) on their reproductive parameters and progeny performance. Two hundred forty meat-type quails at 25 wk of age were distributed in a completely randomized design with 5 treatments and 8 replicates of 6 birds each. The treatments consisted of 5 dietary levels of GAA (0.00, 0.06, 0.12, 0.18, and 0.24%). The progenies from quail breeders were housed according to breeder treatments and fed a conventional diet based on corn and soybean meal without GAA supplementation. Dietary GAA levels did not affect (P > 0.05) the productivity of meat-type quail breeders, although the concentration of guanidinic compounds (creatine, GAA, and creatinine) in the eggs from the breeders increased linearly (P < 0.05) according to the increase in dietary GAA levels. The number of spermatozoa present in the vitelline membrane was not affected (P > 0.05) by the treatments, but there was a quadratic effect (P < 0.05) of the levels of GAA on fertility, embryonic mortality, and egg hatchability, with the best results estimated at 0.13, 0.15, and 0.14% GAA, respectively. The creatine levels of the pectoral muscle in newborn quails showed a quadratic effect (P ≤ 0.07), and the dietary GAA level of 0.11% was estimated to maximize the muscular creatine level in the progeny. There was a quadratic effect (P < 0.05) of GAA levels on weight gain and feed conversion of progeny at 35 d of age with an optimization point of 0.14% GAA for these variables. Dietary GAA supplementation of meat-type quail breeders increases the availability of creatine in eggs and muscle of progeny, which results in better reproductive parameters and better postnatal progeny performance.


Asunto(s)
Coturnix/fisiología , Dieta/veterinaria , Suplementos Dietéticos , Glicina/análogos & derivados , Reproducción/fisiología , Alimentación Animal/análisis , Animales , Cromatografía por Intercambio Iónico/veterinaria , Coturnix/crecimiento & desarrollo , Femenino , Glicina/metabolismo , Masculino , Distribución Aleatoria
18.
Rev. bras. ciênc. avic ; 16(2): 37-42, Apr.-June 2014. tab
Artículo en Inglés | VETINDEX | ID: biblio-1490063

RESUMEN

This study evaluated the effects of different sources of vitamin D and calcium levels on performance, egg quality and bone strength of hens in the second production cycle. A total of 384 Hy-Line W36 birds with 80 weeks of age were used, alloted into 3 x 4 factorial design (sources of vitamin D: cholecalciferol; 25(OH)D3 and 1.25(OH)2D3 x calcium levels: 2.85, 3.65; 4.45 and 5.25%) with four replicates and eight birds each. The performance was evaluated for three cycles of 28 days each, egg quality was evaluated in the last four days of each cycle and bone strength on the last day of the experimental period. There was no interaction (p > 0.05) between the different sources of vitamin D and calcium levels in all parameters evaluated. There was a quadratic effect (p 0.05) in the egg weight and Haugh unit, but there was a linear increase (p < 0.05) in the percentage and eggshell thickness, in specific gravity and bone strength. The different sources of vitamin D influenced (p < 0.05) the egg production rate, feed conversion, egg weight and Haugh unit. Thus, the results of this study suggest that the recommended calcium level for laying on second cycle is between 4.09% and 4.14% and that the metabolites cholecalciferol and 25(OH)D3 improved the performance and egg quality. Regarding bone strength was improved as the calcium levels were increased in diets.


Asunto(s)
Animales , Calcio de la Dieta/análisis , Pollos/crecimiento & desarrollo , Vitamina D/análisis , Vitaminas en la Dieta/análisis , Alimentación Animal/análisis
19.
R. bras. Ci. avíc. ; 16(2): 37-42, Apr.-June 2014. tab
Artículo en Inglés | VETINDEX | ID: vti-15259

RESUMEN

This study evaluated the effects of different sources of vitamin D and calcium levels on performance, egg quality and bone strength of hens in the second production cycle. A total of 384 Hy-Line W36 birds with 80 weeks of age were used, alloted into 3 x 4 factorial design (sources of vitamin D: cholecalciferol; 25(OH)D3 and 1.25(OH)2D3 x calcium levels: 2.85, 3.65; 4.45 and 5.25%) with four replicates and eight birds each. The performance was evaluated for three cycles of 28 days each, egg quality was evaluated in the last four days of each cycle and bone strength on the last day of the experimental period. There was no interaction (p > 0.05) between the different sources of vitamin D and calcium levels in all parameters evaluated. There was a quadratic effect (p < 0.05) of calcium levels in egg production and feed conversion (kg/kg and kg/dz), with better results at levels of 4.12%, 4.09% and 4.14%, respectively. Calcium levels had no effect (p > 0.05) in the egg weight and Haugh unit, but there was a linear increase (p < 0.05) in the percentage and eggshell thickness, in specific gravity and bone strength. The different sources of vitamin D influenced (p < 0.05) the egg production rate, feed conversion, egg weight and Haugh unit. Thus, the results of this study suggest that the recommended calcium level for laying on second cycle is between 4.09% and 4.14% and that the metabolites cholecalciferol and 25(OH)D3 improved the performance and egg quality. Regarding bone strength was improved as the calcium levels were increased in diets.(AU)


Asunto(s)
Animales , Vitamina D/análisis , Calcio de la Dieta/análisis , Vitaminas en la Dieta/análisis , Pollos/crecimiento & desarrollo , Alimentación Animal/análisis
20.
Hum Immunol ; 75(5): 433-9, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24530749

RESUMEN

Macrophage migration inhibitory factor (MIF) is an upstream immunoregulatory cytokine associated with the pathogenesis of autoimmune inflammatory diseases. There is evidence that MIF functions in a positive feedback loop with TNF-α that could perpetuate the inflammatory process in systemic lupus erythematosus (SLE). In this case-control study we investigated whether commonly occurring functional MIF polymorphisms are associated with SLE as well as with MIF and TNF-α serum levels in a Mexican-Mestizo population. Genotyping of the -794 CATT5-8 (rs5844572) and -173 G>C (rs755622) MIF polymorphisms was performed by PCR and PCR-RFLP, respectively in 186 SLE patients and 200 healthy subjects. MIF and TNF-α serum levels were determined by ELISA. A significant increase of MIF and TNF-α levels was found in SLE patients. According to a genetic model, we found a significant association of genotypes carrying the -794 CATT7 and -173(∗)C risk alleles with susceptibility to SLE and with a significant increase of TNF-α. In conclusion, MIF gene polymorphisms are associated with SLE susceptibility and with an increase of TNF-α serum levels in a Mexican-Mestizo population.


Asunto(s)
Predisposición Genética a la Enfermedad , Lupus Eritematoso Sistémico/genética , Factores Inhibidores de la Migración de Macrófagos/genética , Polimorfismo de Nucleótido Simple , Adolescente , Adulto , Anciano , Alelos , Estudios de Casos y Controles , Femenino , Frecuencia de los Genes , Genotipo , Humanos , Lupus Eritematoso Sistémico/sangre , Factores Inhibidores de la Migración de Macrófagos/sangre , Masculino , México , Persona de Mediana Edad , Oportunidad Relativa , Regiones Promotoras Genéticas , Factor de Necrosis Tumoral alfa/sangre , Factor de Necrosis Tumoral alfa/genética , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA